Kennedy Capital Management »

Rapport Therapeutics shares owned by Kennedy Capital Management

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Kennedy Capital Management from 13F filings

Historical chart of Kennedy Capital Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Kennedy Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.4M 179k 30.34
2025-06-30 $128k 11k 11.37